Hirsutism and oligomenorrhea are appropriate screening criteria for polycystic ovary syndrome in adolescents

References

• Villarroel C, Merino PM, Lopez P, et al. Polycystic ovarian morphology in adolescents with regular menstrual cycles is associated with elevated anti-Mullerian hormone. Hum Reprod 2011;26:2861–8
   PubMed Web of Science ®Google Scholar
• Sir-Petermann T, Codner E, Perez V, et al. Metabolic and reproductive features before and during puberty in daughters of women with polycystic ovary syndrome. J Clin Endocrinol Metab 2009;94:1923–30
   PubMed Web of Science ®Google Scholar
• Legro RS, Arslanian SA, Ehrmann DA, et al. Diagnosis and treatment of polycystic ovary syndrome: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2013;98:4565–92
   PubMed Web of Science ®Google Scholar
• American Academy of Pediatrics Committee on A, American College of O, Gynecologists Committee on Adolescent Health C, et al. Menstruation in girls and adolescents: using the menstrual cycle as a vital sign. Pediatrics 2006;118:2245–50
   PubMed Web of Science ®Google Scholar
• Tellez R, Frenkel J. Clinical evaluation of body hair in healthy women. Rev Med Chil 1995;123:1349–54
   PubMed Web of Science ®Google Scholar
• Codner E, Iniguez G, Villarroel, et al. Hormonal profile in women with polycystic ovarian syndrome with or without type 1 diabetes mellitus. J Clin Endocrinol Metab 2007;92:4742–6
   PubMed Web of Science ®Google Scholar
• Codner E, Iniguez G, Hernandez IM, et al. Elevated anti-Mullerian hormone (AMH) and inhibin B levels in prepubertal girls with type 1 diabetes mellitus. Clin Endocrinol (Oxf) 2011;74:73–8
   PubMed Web of Science ®Google Scholar
• Codner E, Mook-Kanamori D, Bazaes RA, et al. Ovarian function during puberty in girls with type 1 diabetes mellitus: response to leuprolide. J Clin Endocrinol Metab 2005. 90:3939–45
   PubMed Web of Science ®Google Scholar
• Codner E, Iniguez G, Villarroel C, et al. Hormonal profile in women with polycystic ovarian syndrome with or without type 1 diabetes mellitus. J Clin Endocrinol Metab 2007;92:4742–6
   PubMed Web of Science ®Google Scholar
• Codner E, Villarroel C, Eyzaguirre FC, et al. Polycystic ovarian morphology in postmenarchal adolescents. Fertil Steril 2011;95:702–6
   PubMed Web of Science ®Google Scholar
• Villarroel C, Trejo L, Munoz A, et al. Assessment of diagnostic competence of plasmatic androgens on polycystic ovary syndrome based on receiver operator characteristic curves. Gynecol Endocrinol 2010;26:600–6
   PubMed Web of Science ®Google Scholar
• Rotterdam ESHRE-ASRM-Sponosored PCOS Consensus Workshop Group 2004 Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81:19–25
   Google Scholar
• Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983;148:839–43
   PubMed Web of Science ®Google Scholar
• Carmina E, Rosato F, Janni A, et al. Extensive clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism. J Clin Endocrinol Metab 2006;91:2–6
   PubMed Web of Science ®Google Scholar
• Azziz R, Sanchez LA, Knochenhauer ES, et al. Androgen excess in women: experience with over 1000 consecutive patients. J Clin Endocrinol Metab 2004;89:453–62
   PubMed Web of Science ®Google Scholar
• Huang A, Brennan K, Azziz R. Prevalence of hyperandrogenemia in the polycystic ovary syndrome diagnosed by the National Institutes of Health 1990 criteria. Fertil Steril 2010;93:1938–41
   PubMed Web of Science ®Google Scholar
• Spencer JB, Klein M, Kumar A, et al. The age-associated decline of androgens in reproductive age and menopausal Black and White women. J Clin Endocrinol Metab 2007;92:4730–3
   PubMed Web of Science ®Google Scholar
• Rosner W, Auchus RJ, Azziz R, et al. Position statement: utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. J Clin Endocrinol Metab 2007;92:405–13
   PubMed Web of Science ®Google Scholar
• Silfen ME, Denburg MR, Manibo AM, et al. Early endocrine, metabolic, and sonographic characteristics of polycystic ovary syndrome (PCOS): comparison between nonobese and obese adolescents. J Clin Endocrinol Metab 2003;88:4682–8
   PubMed Web of Science ®Google Scholar
• Gambineri A, Fanelli F, Prontera O, et al. Prevalence of hyperandrogenic states in late adolescent and young women: epidemiological survey on italian high-school students. J Clin Endocrinol Metab 2013;98:1641–50
   PubMed Web of Science ®Google Scholar
• Carmina E, Oberfield SE, Lobo RA. The diagnosis of polycystic ovary syndrome in adolescents. Am J Obstet Gynecol 2010;203:201 e1–5
   PubMed Web of Science ®Google Scholar
• Rieder J, Santoro N, Cohen HW, et al. Body shape and size and insulin resistance as early clinical predictors of hyperandrogenic anovulation in ethnic minority adolescent girls. J Adolesc Health 2008;43:115–24
   PubMed Web of Science ®Google Scholar
• Fruzzetti F, Perini D, Lazzarini V, et al. Adolescent girls with polycystic ovary syndrome showing different phenotypes have a different metabolic profile associated with increasing androgen levels. Fertil Steril 2009;92:626–34
   PubMed Web of Science ®Google Scholar
• Bentzen JG, Forman JL, Johannsen TH, et al. Ovarian antral follicle subclasses and anti-mullerian hormone during normal reproductive aging. J Clin Endocrinol Metab 2013;98:1602–11
   PubMed Web of Science ®Google Scholar
• Barber TM, Alvey C, Greenslade T, et al. Patterns of ovarian morphology in polycystic ovary syndrome: a study utilising magnetic resonance imaging. Eur Radiol 2010;20:1207–13
   PubMed Web of Science ®Google Scholar
• Pigny P, Merlen E, Robert Y, et al. Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest. J Clin Endocrinol Metab 2003;88:5957–62
   PubMed Web of Science ®Google Scholar
• Rosenfield RL, Wroblewski K, Padmanabhan V, et al. Antimullerian hormone levels are independently related to ovarian hyperandrogenism and polycystic ovaries. Fertil Steril 2012;98:242–9
   PubMed Web of Science ®Google Scholar
• Hart R, Doherty DA, Norman RJ, et al. Serum antimullerian hormone (AMH) levels are elevated in adolescent girls with polycystic ovaries and the polycystic ovarian syndrome (PCOS). Fertil Steril 2010;94:1118–21
   PubMed Web of Science ®Google Scholar
• Pawelczak M, Kenigsberg L, Milla S, et al. Elevated serum anti-Mullerian hormone in adolescents with polycystic ovary syndrome: relationship to ultrasound features. J Pediatr Endocrinol Metab 2012;25:983–9
   PubMed Web of Science ®Google Scholar
• Chu MC, Carmina E, Wang J, et al. Mullerian-inhibiting substance reflects ovarian findings in women with polycystic ovary syndrome better than does inhibin B. Fertil Steril 2005;84:1685–8
   PubMed Web of Science ®Google Scholar